General Information:

Id: 3,512
Diseases: Diabetes mellitus, type II - [OMIM]
Insulin resistance
Obesity - [OMIM]
Homo sapiens
article
Reference: Newgard CB et al.(2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance Cell Metab. 9: 311-326 [PMID: 19356713]

Interaction Information:

Comment Obese subjects had twice as much total fat mass as lean controls, but only a 17% increase in lean mass. The higher total fat mass in obese subjects was accompanied by a 2.3-fold increase in subcutaneous fat mass and a 3.1-fold increase in visceral fat mass.
Formal Description
Interaction-ID: 32629

disease

Obesity

increases_quantity of

tissue/cell line

abdominal adipose tissue

Comment Respiratory exchange rate (RER), also known as respiratory quotient (RQ), was significantly higher in obese subjects. Thus, obese subjects appear to have a preference for oxidation of nonlipid fuels (glucose and amino acids) compared to lean controls (as indicated by the higher RQ), even though they have substantially larger total, subcutaneous, and visceral fat depots.
Formal Description
Interaction-ID: 32635

disease

Obesity

increases_activity of

Comment Obese subjects were less insulin sensitive than the lean controls.
Formal Description
Interaction-ID: 32636

disease

Obesity

increases_activity of

phenotype

decreased insulin sensitivity

Comment Among a total of 19 hormones of energy balance and metabolic regulation measured in this study, only 5 were not significantly different in obese versus lean subjects: amylin, glucagon-like peptide-1 (GLP-1), resistin, pancreatic polypeptide, and insulin-like growth factor binding protein-3 (IGFBP-3).
Formal Description
Interaction-ID: 32639

disease

Obesity

NOT affects_quantity of

gene/protein

IAPP

in blood serum
Comment Among a total of 19 hormones of energy balance and metabolic regulation measured in this study, only 5 were not significantly different in obese versus lean subjects: amylin, glucagon-like peptide-1 (GLP-1), resistin, pancreatic polypeptide, and insulin-like growth factor binding protein-3 (IGFBP-3).
Formal Description
Interaction-ID: 32642

disease

Obesity

NOT affects_quantity of

in blood serum
Comment Among a total of 19 hormones of energy balance and metabolic regulation measured in this study, only 5 were not significantly different in obese versus lean subjects: amylin, glucagon-like peptide-1 (GLP-1), resistin, pancreatic polypeptide, and insulin-like growth factor binding protein-3 (IGFBP-3).
Formal Description
Interaction-ID: 32644

disease

Obesity

NOT affects_quantity of

gene/protein

RETN

in blood serum
Comment Among a total of 19 hormones of energy balance and metabolic regulation measured in this study, only 5 were not significantly different in obese versus lean subjects: amylin, glucagon-like peptide-1 (GLP-1), resistin, pancreatic polypeptide, and insulin-like growth factor binding protein-3 (IGFBP-3).
Formal Description
Interaction-ID: 32645

disease

Obesity

NOT affects_quantity of

gene/protein

Pancreatic hormone

in blood serum
Comment Among a total of 19 hormones of energy balance and metabolic regulation measured in this study, only 5 were not significantly different in obese versus lean subjects: amylin, glucagon-like peptide-1 (GLP-1), resistin, pancreatic polypeptide, and insulin-like growth factor binding protein-3 (IGFBP-3).
Formal Description
Interaction-ID: 32646

disease

Obesity

NOT affects_quantity of

gene/protein

IGFBP3

in blood serum
Drugbank entries Show/Hide entries for IGFBP3
Comment Pancreatic islet peptides other than amylin (insulin, C-peptide, and glucagon) were all significantly elevated in serum of obese versus lean subjects.
Formal Description
Interaction-ID: 32647

disease

Obesity

increases_quantity of

complex/PPI

Insulin

in blood serum
Comment Pancreatic islet peptides other than amylin (insulin, C-peptide, and glucagon) were all significantly elevated in serum of obese versus lean subjects.
Formal Description
Interaction-ID: 32648

disease

Obesity

increases_quantity of

gene/protein

C-peptide

in blood serum
Comment Pancreatic islet peptides other than amylin (insulin, C-peptide, and glucagon) were all significantly elevated in serum of obese versus lean subjects.
Formal Description
Interaction-ID: 32649

disease

Obesity

increases_quantity of

gene/protein

Glucagon

in blood serum
Comment Levels of the incretin hormone gastric inhibitory polypeptide (GIP) were higher, in accord with the higher insulin levels in obese versus lean subjects.
Formal Description
Interaction-ID: 32650

disease

Obesity

increases_quantity of

gene/protein

GIP

in blood serum
Comment The adipocyte-derived hormones leptin and adiponectin were reciprocally altered by obesity, such that leptin levels were 3.8-fold higher in obese subjects, whereas adiponectin levels were 37% lower.
Formal Description
Interaction-ID: 32653

disease

Obesity

increases_quantity of

gene/protein

LEP

in blood serum
Comment The adipocyte-derived hormones leptin and adiponectin were reciprocally altered by obesity, such that leptin levels were 3.8-fold higher in obese subjects, whereas adiponectin levels were 37% lower.
Formal Description
Interaction-ID: 32654

disease

Obesity

increases_quantity of

gene/protein

ADIPOQ

in blood serum
Comment Among hormones that have been implicated in control of food intake, the gut-derived orexigenic peptide ghrelin was 30% lower in serum of obese subjects, whereas neuropeptide Y (NPY) (orexigenic) and peptide YY (PYY) (presumed antiorexigenic) were 15% and 37% higher, respectively.
Formal Description
Interaction-ID: 32655

disease

Obesity

decreases_quantity of

gene/protein

Ghrelin

in blood serum
Comment Among hormones that have been implicated in control of food intake, the gut-derived orexigenic peptide ghrelin was 30% lower in serum of obese subjects, whereas neuropeptide Y (NPY) (orexigenic) and peptide YY (PYY) (presumed antiorexigenic) were 15% and 37% higher, respectively.
Formal Description
Interaction-ID: 32656

disease

Obesity

increases_quantity of

gene/protein

Neuropeptide Y

in blood serum
Comment Among hormones that have been implicated in control of food intake, the gut-derived orexigenic peptide ghrelin was 30% lower in serum of obese subjects, whereas neuropeptide Y (NPY) (orexigenic) and peptide YY (PYY) (presumed antiorexigenic) were 15% and 37% higher, respectively.
Formal Description
Interaction-ID: 32657

disease

Obesity

increases_quantity of

gene/protein

Peptide YY

in blood serum
Comment Human growth hormone (hGH) trended lower, and total IGF-1, IGFBP-1, and IGFBP-2 were all dramatically lower in serum of obese subjects.
Formal Description
Interaction-ID: 32658

disease

Obesity

decreases_quantity of

gene/protein

IGF1

in blood serum
Drugbank entries Show/Hide entries for IGF1
Comment Human growth hormone (hGH) trended lower, and total IGF-1, IGFBP-1, and IGFBP-2 were all dramatically lower in serum of obese subjects.
Formal Description
Interaction-ID: 32659

disease

Obesity

decreases_quantity of

gene/protein

IGFBP1

in blood serum
Comment Human growth hormone (hGH) trended lower, and total IGF-1, IGFBP-1, and IGFBP-2 were all dramatically lower in serum of obese subjects.
Formal Description
Interaction-ID: 32660

disease

Obesity

decreases_quantity of

gene/protein

IGFBP2

in blood serum
Comment Among the pro- and anti-inflammatory cytokines measured, neither IL-6 nor TNF-alpha differed between obese and lean subjects, whereas IL-10 trended lower in the obese subjects.
Formal Description
Interaction-ID: 32661

disease

Obesity

NOT affects_quantity of

gene/protein

IL6

in blood serum
Drugbank entries Show/Hide entries for IL6
Comment Among the pro- and anti-inflammatory cytokines measured, neither IL-6 nor TNF-alpha differed between obese and lean subjects, whereas IL-10 trended lower in the obese subjects.
Formal Description
Interaction-ID: 32662

disease

Obesity

NOT affects_quantity of

gene/protein

TNF

in blood serum
Drugbank entries Show/Hide entries for TNF
Comment In contrast, C-reactive protein (CRP) levels were 5.3-fold higher in obese subjects.
Formal Description
Interaction-ID: 32663

disease

Obesity

increases_quantity of

gene/protein

CRP

in blood serum
Drugbank entries Show/Hide entries for CRP
Comment Obese subjects had significantly higher levels of nonesterified free fatty acids and triglycerides and substantially lower high-density lipoprotein (HDL) cholesterol.
Formal Description
Interaction-ID: 32666

disease

Obesity

increases_quantity of

drug/chemical compound

Fatty acid

in blood serum
Comment Obese subjects had significantly higher levels of nonesterified free fatty acids and triglycerides and substantially lower high-density lipoprotein (HDL) cholesterol.
Formal Description
Interaction-ID: 32667

disease

Obesity

increases_quantity of

drug/chemical compound

Triacylglycerol

in blood serum
Comment Obese subjects had significantly higher levels of nonesterified free fatty acids and triglycerides and substantially lower high-density lipoprotein (HDL) cholesterol.
Formal Description
Interaction-ID: 32668

disease

Obesity

decreases_quantity of

complex/PPI

HDL

in blood serum
Comment Levels of ketones (total and beta-hydroxybutyrate), byproducts of lipid catabolism, were not different between the groups, whereas levels of pyruvate and lactate, products of carbohydrate catabolism, were higher in serum of obese subjects. These findings appear consistent with the increase in RQ observed in the obese subjects.
Formal Description
Interaction-ID: 32669

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Ketone

in blood serum
Comment Levels of ketones (total and beta-hydroxybutyrate), byproducts of lipid catabolism, were not different between the groups, whereas levels of pyruvate and lactate, products of carbohydrate catabolism, were higher in serum of obese subjects. These findings appear consistent with the increase in RQ observed in the obese subjects.
Formal Description
Interaction-ID: 32673

disease

Obesity

NOT affects_quantity of

drug/chemical compound

(R)-3-Hydroxybutanoate

in blood serum
Comment Levels of ketones (total and beta-hydroxybutyrate), byproducts of lipid catabolism, were not different between the groups, whereas levels of pyruvate and lactate, products of carbohydrate catabolism, were higher in serum of obese subjects. These findings appear consistent with the increase in RQ observed in the obese subjects.
Formal Description
Interaction-ID: 32674

disease

Obesity

increases_quantity of

drug/chemical compound

Pyruvate

in blood serum
Comment Levels of ketones (total and beta-hydroxybutyrate), byproducts of lipid catabolism, were not different between the groups, whereas levels of pyruvate and lactate, products of carbohydrate catabolism, were higher in serum of obese subjects. These findings appear consistent with the increase in RQ observed in the obese subjects.
Formal Description
Interaction-ID: 32676

disease

Obesity

increases_quantity of

drug/chemical compound

Lactate

in blood serum
Comment Among free fatty acids, five of the eight species measured were significantly higher in obese compared to lean subjects (C14:0, C16:0, C16:1, C18:1, C20:4). The rise in C16:1 (palmitoleate) in insulin-resistant and obese subjects is of interest in light of a recent study suggesting that C16:1 promotes insulin sensitivity in skeletal muscle.
Formal Description
Interaction-ID: 32677

disease

Obesity

increases_quantity of

drug/chemical compound

Myristic acid

in blood serum
Drugbank entries Show/Hide entries for
Comment Among free fatty acids, five of the eight species measured were significantly higher in obese compared to lean subjects (C14:0, C16:0, C16:1, C18:1, C20:4). The rise in C16:1 (palmitoleate) in insulin-resistant and obese subjects is of interest in light of a recent study suggesting that C16:1 promotes insulin sensitivity in skeletal muscle.
Formal Description
Interaction-ID: 32678

disease

Obesity

increases_quantity of

drug/chemical compound

Palmitic acid

in blood serum
Drugbank entries Show/Hide entries for
Comment Among free fatty acids, five of the eight species measured were significantly higher in obese compared to lean subjects (C14:0, C16:0, C16:1, C18:1, C20:4). The rise in C16:1 (palmitoleate) in insulin-resistant and obese subjects is of interest in light of a recent study suggesting that C16:1 promotes insulin sensitivity in skeletal muscle.
Formal Description
Interaction-ID: 32679

disease

Obesity

increases_quantity of

drug/chemical compound

Palmitoleic acid

in blood serum
Drugbank entries Show/Hide entries for
Comment Among free fatty acids, five of the eight species measured were significantly higher in obese compared to lean subjects (C14:0, C16:0, C16:1, C18:1, C20:4). The rise in C16:1 (palmitoleate) in insulin-resistant and obese subjects is of interest in light of a recent study suggesting that C16:1 promotes insulin sensitivity in skeletal muscle.
Formal Description
Interaction-ID: 32680

disease

Obesity

increases_quantity of

drug/chemical compound

Oleic acid

in blood serum
Drugbank entries Show/Hide entries for
Comment Among free fatty acids, five of the eight species measured were significantly higher in obese compared to lean subjects (C14:0, C16:0, C16:1, C18:1, C20:4). The rise in C16:1 (palmitoleate) in insulin-resistant and obese subjects is of interest in light of a recent study suggesting that C16:1 promotes insulin sensitivity in skeletal muscle.
Formal Description
Interaction-ID: 32681

disease

Obesity

increases_quantity of

drug/chemical compound

Arachidonic acid

in blood serum
Drugbank entries Show/Hide entries for
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32682

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Citrulline

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32683

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Histidine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32684

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Methionine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32685

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Ornithine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32686

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Proline

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32687

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Serine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32689

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Tryptophan

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32690

disease

Obesity

increases_quantity of

drug/chemical compound

Alanine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32691

disease

Obesity

increases_quantity of

drug/chemical compound

Valine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32692

disease

Obesity

increases_quantity of

drug/chemical compound

Leucine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32693

disease

Obesity

increases_quantity of

drug/chemical compound

Isoleucine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32694

disease

Obesity

increases_quantity of

drug/chemical compound

Phenylalanine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32695

disease

Obesity

increases_quantity of

drug/chemical compound

Tyrosine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32696

disease

Obesity

increases_quantity of

drug/chemical compound

Glutamate

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32697

disease

Obesity

increases_quantity of

drug/chemical compound

Glutamine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32698

disease

Obesity

increases_quantity of

drug/chemical compound

Aspartate

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32699

disease

Obesity

increases_quantity of

drug/chemical compound

Asparagine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32701

disease

Obesity

increases_quantity of

drug/chemical compound

Arginine

in blood serum
Comment Among a total of 16 amino acids measured in the serum, 7 were not different in obese versus lean subjects (citrulline, histidine, methionine, ornithine, proline, serine, tryptophan). Eight other amino acids were dramatically elevated in obese versus lean participants (alanine, valine, leucine/isoleucine, phenylalanine, tyrosine, glutamate/ glutamine, aspartate/asparagine, arginine), whereas glycine levels were lower in obese subjects.
Formal Description
Interaction-ID: 32702

disease

Obesity

decreases_quantity of

drug/chemical compound

Glycine

in blood serum
Drugbank entries Show/Hide entries for
Comment Among 37 acylcarnitine species measured, only 4 were significantly higher in obese subjects (C3, C5, C6, C8:1).
Formal Description
Interaction-ID: 32704

disease

Obesity

increases_quantity of

drug/chemical compound

Propanoylcarnitine

in blood serum
Comment Among 37 acylcarnitine species measured, only 4 were significantly higher in obese subjects (C3, C5, C6, C8:1).
Formal Description
Interaction-ID: 32710

disease

Obesity

increases_quantity of

drug/chemical compound

Alpha-methylbutyrylcarnitine

in blood serum
Comment Among 37 acylcarnitine species measured, only 4 were significantly higher in obese subjects (C3, C5, C6, C8:1).
Formal Description
Interaction-ID: 32712

disease

Obesity

increases_quantity of

drug/chemical compound

Isovalerylcarnitine

in blood serum
Comment Among 37 acylcarnitine species measured, only 4 were significantly higher in obese subjects (C3, C5, C6, C8:1).
Formal Description
Interaction-ID: 32714

disease

Obesity

increases_quantity of

drug/chemical compound

Hexanoylcarnitine

in blood serum
Comment Among 37 acylcarnitine species measured, only 4 were significantly higher in obese subjects (C3, C5, C6, C8:1).
Formal Description
Interaction-ID: 32715

disease

Obesity

increases_quantity of

drug/chemical compound

Acylcarnitine C8:1

in blood serum
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32716

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Methylmalonate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32722

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Succinate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32723

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Methylsuccinate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32724

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Fumarate

in urine
Drugbank entries Show/Hide entries for
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32725

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Glutarate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32726

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Butyrylglycine

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32727

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Malate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32728

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Adipate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32729

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Hexanoylglycine

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32730

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Suberate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32731

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Orotate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32732

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Homovanillate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32733

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Citrate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32734

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Pyruvate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32735

disease

Obesity

NOT affects_quantity of

drug/chemical compound

Lactate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32736

disease

Obesity

increases_quantity of

drug/chemical compound

Ethylmalonate

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32737

disease

Obesity

decreases_quantity of

drug/chemical compound

Isobutyrylglycine

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32738

disease

Obesity

decreases_quantity of

drug/chemical compound

Isovalerylglycine

in urine
Comment Among 20 organic acids measured in urine by GC/MS, 15 were not different in obese versus lean subjects (methylmalonate, succinate, methylsuccinate, fumarate, glutarate, butyrylglycine, malate, adipate, hexanoyl glycine, suberate, orotate, homovanillic, citrate, pyruvate, lactate). Levels of ethylmalonate were significantly higher, and levels of isobutyryl glycine, isovaleryl glycine, and alpha-ketoglutarate were lower in urine samples from obese compared to lean subjects.
Formal Description
Interaction-ID: 32740

disease

Obesity

decreases_quantity of

drug/chemical compound

2-Oxoglutarate

in urine
Comment In the physiological context of overnutrition and low IGF-1 levels, as found in obese subjects, circulating BCAAs rise, leading to increased flux of these amino acids through their catabolic pathways.
Formal Description
Interaction-ID: 32778

disease

Obesity

increases_activity of

phenotype

increased circulating branched-chain amino acid level

Comment In the physiological context of overnutrition and low IGF-1 levels, as found in obese subjects, circulating BCAAs rise, leading to increased flux of these amino acids through their catabolic pathways.
Formal Description
Interaction-ID: 32779

phenotype

increased circulating branched-chain amino acid level

increases_activity of

Comment A high rate of flux through BCAA catabolic pathways and accumulation of glutamate may increase transamination of pyruvate to alanine. Increases in alanine, a highly gluconeogenic amino acid, could contribute to development of glucose intolerance in obesity. Indeed, circulating pyruvate and alanine levels are clearly elevated in the obese subjects.
Formal Description
Interaction-ID: 32789

drug/chemical compound

Alanine

increases_activity of

process

gluconeogenesis